Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease (Q36327367)

13 August 2017

1 reference

title

Targeting the TCR: T-cell receptor and peptide-specific tolerance-based strategies for restoring self-tolerance in CNS autoimmune disease (English)

1 reference

13 August 2017

1 reference

Adam P Kohm

1

1 reference

13 August 2017

Danielle M Turley

series ordinal

2

1 reference

13 August 2017

Stephen D Miller

series ordinal

3

1 reference

13 August 2017

publication date

1 September 2005

1 reference

International Reviews of Immunology

13 August 2017

published in

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

5-6

1 reference

13 August 2017

page(s)

361-392

1 reference

A genetic basis for familial aggregation in multiple sclerosis. Canadian Collaborative Study Group

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Multiple sclerosis. More genes versus environment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Virus-induced autoimmunity: potential role of viruses in initiation, perpetuation, and progression of T-cell-mediated autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Amino acid homology between the encephalitogenic site of myelin basic protein and virus: mechanism for autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Molecular mimicry in T cell-mediated autoimmunity: viral peptides activate human T cell clones specific for myelin basic protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

The immunopathogenesis and regulation of T-cell-mediated demyelinating diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Initiation of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Monoclonal antibody therapy in experimental allergic encephalomyelitis and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

The T cell receptor: critical role of the membrane environment in receptor assembly and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Identification of a monoclonal antibody specific for a murine T3 polypeptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

CD3-specific antibody-induced active tolerance: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

An open trial of OKT3 in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Hypothermia and hypoglycemia induced by anti-CD3 monoclonal antibody in mice: role of tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Prevention of autoimmune diabetes with nonactivating anti-CD3 monoclonal antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

The generation of a humanized, non-mitogenic CD3 monoclonal antibody which retains in vitro immunosuppressive properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Surface expression of alpha 4 integrin by CD4 T cells is required for their entry into brain parenchyma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Activation of human T cells by FcR nonbinding anti-CD3 mAb, hOKT3gamma1(Ala-Ala).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Induction of Th1 and Th2 CD4+ T cell responses: the alternative approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Nonmitogenic anti-CD3 monoclonal antibodies deliver a partial T cell receptor signal and induce clonal anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Regulatory T cells in spontaneous autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Suppressor T cells--they're back and critical for regulation of autoimmunity!

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Selection and fine-tuning of the autoimmune T-cell repertoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Antigen recognition in autoimmune encephalomyelitis and the potential for peptide-mediated immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

A pilot trial of Cop 1 in exacerbating-remitting multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Copolymer 1 acts against the immunodominant epitope 82-100 of myelin basic protein by T cell receptor antagonism in addition to major histocompatibility complex blocking

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Safety profile of copolymer 1: analysis of cumulative experience in the United States and Israel.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Therapeutic potential of oral tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Induction of anergy or active suppression following oral tolerance is determined by antigen dosage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Oral tolerance: overview and historical perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Current issues in the treatment of human diseases by mucosal tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Nasal administration of myelin basic protein prevents relapsing experimental autoimmune encephalomyelitis in DA rats by activating regulatory cells expressing IL-4 and TGF-beta mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Double-Blind Pilot Trial of Oral Tolerization with Myelin Antigens in Multiple Sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Visualization of peptide-specific T cell immunity and peripheral tolerance induction in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Tolerance induction and autoimmune encephalomyelitis amelioration after administration of myelin basic protein-derived peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Late complications of immune deviation therapy in a nonhuman primate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

An unexpected version of horror autotoxicus: anaphylactic shock to a self-peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Evolution of the T‐Cell Repertoire during the Course of Experimental Immune‐Mediated Demyelinating Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Inhibition of experimental autoimmune uveitis by retinal photoreceptor antigens coupled to spleen cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Antigen-specific inhibition of the adoptive transfer of experimental autoimmune encephalomyelitis in Lewis rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

CH3 domain of IgG as binding site to Fc receptor on mouse lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

The role of CTLA-4 in induction and maintenance of peripheral T cell tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500371207

10.1080/08830180500371207

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference